Abnormalities in 3-Dimensional Left Ventricular Mechanics With Anthracycline Chemotherapy Are Associated With Systolic and Diastolic Dysfunction

Clinical Trial | By KW Zhang, BS Finkelman, G Gulati et al.

The Comparison of Clinical Outcomes After Drug-Eluting Balloon and Drug-Eluting Stent Use for Left Main Bifurcation In-Stent Restenosis

Clinical Trial | By Lee WC, Hsueh SK, Chen CJ et al.

ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: A Report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography

| By Patel MR, Dehmer GJ, American College of Cardiology Foundation Appropriateness Criteria Task Force et al.

Long-Term Outcomes of Different Two-Stent Techniques With Second-Generation Drug-Eluting Stents for Unprotected Left Main Bifurcation Disease: Insights From the FAILS-2 Study

Clinical Trial | By Pavani M, Conrotto F, Cerrato E et al.

Long-term outcomes following mini-crush versus culotte stenting for the treatment of unprotected left main disease: insights from the Milan and New-Tokyo (MITO) registry

Clinical Trial | By Kawamoto H, Takagi K, Colombo A et al.

Left main coronary artery disease: importance, diagnosis, assessment, and management

Review Article | By Ragosta M.

Percutaneous coronary intervention for coronary bifurcation disease: 11th consensus document from the European Bifurcation Club

Consensus | By Lassen JF, Holm NR, Banning A et al.

Incidence and Management of Restenosis After Treatment of Unprotected Left Main Disease With Second-Generation Drug-Eluting Stents (from Failure in Left Main Study With 2nd Generation Stents-Cardiogroup III Study)

Original Research | By D'Ascenzo F, Chieffo A, Cerrato E et al.

Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation

Original Research | By Park SJ, Kim YH, Lee BK et al.

Long-term safety and effectiveness of unprotected left main coronary stenting with drug-eluting stents compared with bare-metal stents

Original Research | By Kim YH, Park DW, Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization Investigators et al.